Mostrar registro simples

dc.contributor.authorCatelli, Dayenne Helenapt_BR
dc.contributor.authorPortich, Julia Plentzpt_BR
dc.contributor.authorLuz, Adriana Celiapt_BR
dc.contributor.authorDiaz, Giovana Fecker da Costapt_BR
dc.contributor.authorOurique, Liliane Ourique dept_BR
dc.contributor.authorHoffmann, Daniel Sanderpt_BR
dc.contributor.authorBosi, Guilherme Rasiapt_BR
dc.contributor.authorSpessato, Barbara Coiropt_BR
dc.contributor.authorSekine, Leopt_BR
dc.contributor.authorSilla, Lucia Mariano da Rochapt_BR
dc.date.accessioned2021-08-05T04:29:36Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn2357-9730pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/225131pt_BR
dc.description.abstractIntroduction: Epidemiological studies on hemophilia in the Brazilian population are historically scarce. Despite the continuous effort made by the National Program of Inherited Bleeding Disorders to map this condition, little information is available, especially on the period prior to program conception. Therefore, the present study aims to assess the epidemiological, serological, and clinical characteristics of patients with hemophilia in the state of Rio Grande do Sul, Brazil. Methods: A total of 455 patients had their medical records reviewed from January 1, 2003 to December 31, 2007. Results: We observed a remarkable prevalence of hepatitis C virus (HCV) infection in patients with both hemophilia A and B, and this prevalence significantly increased along with age (p < 0.001). No positive anti-HCV results were observed among children younger than 5 years old. There was a significant correlation between the severity of hemophilia and the number of arthropathies in all age categories. Considering the presence of inhibitors, a significant difference was observed between age groups, as older patients had higher inhibitor titers. There was a significant correlation between mean coagulation factor consumption and the number of arthropathies in patients over 5 years old. Conclusions: This profile analysis of patients with hemophilia reflects a gradual improvement in treatment safety and efficiency, as well as the need for continued investment in this population.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofClinical and biomedical research. Porto Alegre. vol. 41, no. 1 (2021), p. 1-5.pt_BR
dc.rightsOpen Accessen
dc.subjectHemofiliapt_BR
dc.subjectHemophiliaen
dc.subjectEpidemiologyen
dc.subjectEstudos de coortespt_BR
dc.subjectArthropathyen
dc.subjectHepatitept_BR
dc.subjectState of Rio Grande do Sulen
dc.subjectBrazilen
dc.titleEpidemiological characteristics of hemophilia in the pre-primary prophylaxis era : a historical cohortpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001129152pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples